Literature DB >> 11874839

Influence of prior pregnancies on disease course and cause of death in systemic sclerosis.

C M Artlett1, M Rasheed, K E Russo-Stieglitz, H H B Sawaya, S A Jimenez.   

Abstract

BACKGROUND: Microchimerism from fetal or maternal cells transferred during pregnancy has been implicated in the pathogenesis of systemic sclerosis (SSc).
OBJECTIVE: To determine whether a prior pregnancy influenced disease progression and cause of death in patients with SSc. PATIENTS AND METHODS: The patients comprised a retrospective study cohort of 111 women with SSc: 78 patients with prior pregnancies (PP) and 33 who were never pregnant (NP), followed up at Thomas Jefferson University. Differences in age at onset, disease subset, organ involvement, cause of death, and type of antinuclear autoantibodies were evaluated statistically, including regression analysis.
RESULTS: The age at onset of SSc in NP patients was 32.0 years compared with 45.7 years in patients with one or two prior pregnancies (p<0.0001), 46.6 years in patients with three or four pregnancies (p<0.0001), and 51.3 years in patients with five to seven pregnancies (p<0.0005). In the 16 patients who had an elective pregnancy termination, 14/16 (87.5%) had diffuse SSc v 2/16 (12.5%) with limited SSc (p<0.0001; odds ratio (OR)=49.0). Of the NP women, 7/30 (23%) died from SSc related causes v 3/78 (4%) women who had pregnancies (p=0.0058; OR=7.6). A carbon monoxide transfer factor (TLCO) of <60% and disease duration >10 years was found in 10/13 (77%) NP patients v 10/23 (43%) patients who had pregnancies (p=0.05; OR=4.7), and a TLCO <50% and disease duration >10 years was identified in 7/13 (54%) NP patients v 6/23 (26%) of the patients who had pregnancies (p=0.09; OR=3.2).
CONCLUSIONS: There are differences in the age at onset, clinical course, severity of lung involvement, and cause of death in women who develop SSc before pregnancy compared with those who develop it after pregnancies. The NP patients with SSc had onset of disease at an earlier age, more severe lung involvement, and higher rate of death due to SSc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874839      PMCID: PMC1754050          DOI: 10.1136/ard.61.4.346

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  39 in total

1.  SCLERODERMA AND PREGNANCY.

Authors:  T R JOHNSON; E A BANNER; R K WINKELMANN
Journal:  Obstet Gynecol       Date:  1964-03       Impact factor: 7.661

2.  Cellular infiltrates in scleroderma skin.

Authors:  R Fleischmajer; J S Perlish; J R Reeves
Journal:  Arthritis Rheum       Date:  1977-05

3.  Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease.

Authors:  T J Lawley; G L Peck; H M Moutsopoulos; A A Gratwohl; A B Deisseroth
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

4.  Scleroderma and pregnancy.

Authors:  W G Slate; A R Graham
Journal:  Am J Obstet Gynecol       Date:  1968-06-01       Impact factor: 8.661

5.  Scleroderma-like graft-versus-host disease as late consequence of bone-marrow grafting.

Authors:  M A Siimes; E Johansson; J Rapola
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

6.  Microchimerism in pregnant mice.

Authors:  A Liegeois; M C Gaillard; E Ouvre; D Lewin
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

7.  Relationship between parity and clinical and biological features in patients with systemic sclerosis.

Authors:  D Launay; M Hebbar; P Y Hatron; U Michon-Pasturel; V Queyrel; E Hachulla; B Devulder
Journal:  J Rheumatol       Date:  2001-03       Impact factor: 4.666

8.  Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group.

Authors:  C M Artlett; R Ramos; S A Jiminez; K Patterson; F W Miller; L G Rider
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

Review 9.  Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy.

Authors:  M P Piccinni; C Scaletti; E Maggi; S Romagnani
Journal:  J Neuroimmunol       Date:  2000-09-01       Impact factor: 3.478

10.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05
View more
  11 in total

1.  Birth order and narcolepsy risk among genetically susceptible individuals: a population-based case-control study.

Authors:  Nathaniel F Watson; Thanh G N Ton; Thomas D Koepsell; W T Longstreth
Journal:  Sleep Med       Date:  2012-01-26       Impact factor: 3.492

2.  Pregnancy and primary biliary cirrhosis: a case-control study.

Authors:  Annarosa Floreani; Chiara Infantolino; Irene Franceschet; Ivette Magne Tene; Nora Cazzagon; Alessandra Buja; Vincenzo Baldo; M Eric Gershwin; Maria Teresa Gervasi
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

3.  Separate influences of birth order and gravidity/parity on the development of systemic sclerosis.

Authors:  Tonya Cockrill; Deborah J del Junco; Frank C Arnett; Shervin Assassi; Filemon K Tan; Terry McNearney; Michael Fischbach; Marilyn Perry; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

Review 4.  Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.

Authors:  Stevan P Tofovic
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

5.  Occupational silica exposure as a risk factor for scleroderma: a meta-analysis.

Authors:  Zachary D McCormic; Sura S Khuder; Bishwa K Aryal; April L Ames; Sadik A Khuder
Journal:  Int Arch Occup Environ Health       Date:  2010-01-03       Impact factor: 3.015

6.  2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats.

Authors:  Stevan P Tofovic; Xinchen Zhang; Edwin K Jackson; Hong Zhu; Gordana Petrusevska
Journal:  Vascul Pharmacol       Date:  2009-06-21       Impact factor: 5.773

7.  Pre-disease pregnancy complications and systemic sclerosis: pathogenic or pre-clinical?

Authors:  Eliza Chakravarty
Journal:  Arthritis Res Ther       Date:  2012-02-06       Impact factor: 5.156

Review 8.  Microchimerism and scleroderma: an update.

Authors:  Carol M Artlett
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

Review 9.  Why are women predisposed to autoimmune rheumatic diseases?

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

Review 10.  Systemic Sclerosis and Malignancy: A Review of Current Data.

Authors:  Nabil Zeineddine; Lara El Khoury; Joseph Mosak
Journal:  J Clin Med Res       Date:  2016-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.